# VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

> **NCT04403139** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Washington** · enrollment: 50 (estimated)

## Conditions studied

- Varicella Zoster Virus Infection

## Interventions

- **DRUG:** Shingrix

## Key facts

- **NCT ID:** NCT04403139
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-27
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403139, "VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04403139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*